Boothbay Fund Management, LLC Immuno Precise Antibodies Ltd. Transaction History
Boothbay Fund Management, LLC
- $3.37 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.66MCall Options Held
14.1KPut Options Held
6.9K-
Ingalls & Snyder LLC New York, NY1.3MShares$854,9910.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.9KShares$42,1800.0% of portfolio
-
Bank Of Montreal Toronto, A655.9KShares$36,8650.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$33,4810.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$27,1920.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $16.4M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...